Before and after improvements may include brighter skin, a more even complexion, and enhanced skin clarity, but these outcomes are best achieved through medically supervised care
Ajoolabady A, Pratico D, Tang D, et al
Continued research and well-designed clinical trials are essential to validate its benefits and ensure its safe application in medical practice
Medical Disclaimer: Ozempic 0.5mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional
Approval (2017) Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation (May 17, 2025) Semaglutide (February 11, 2024) Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial (March 23, 2021) Weight Regain And Cardiometabolic Effects After Withdrawal Of Semaglutide: The Step 1 Trial Extension (May 19, 2022)